Coldstream Capital Management Inc Hutchmed (China) LTD Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Coldstream Capital Management Inc holds 102 shares of HCM stock, worth $1,627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
102Holding current value
$1,627% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HCM
# of Institutions
63Shares Held
6.44MCall Options Held
9.9KPut Options Held
9.6K-
Schroder Investment Management Group London, X02.84MShares$45.4 Million0.05% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1MShares$16 Million0.02% of portfolio
-
State Street Corp Boston, MA337KShares$5.38 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$5.03 Million0.13% of portfolio
-
M&G PLC London, X0259KShares$4.13 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.76B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...